skip to main content
Global Search Configuration



The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for over 40 years.


With 90,000+ drug profiles, including 20,000 drugs in active development, it’s the go-to resource for tracking and analyzing the global drug research and development landscape across all disease areas from preclinical to launch. 


Icons_Pharma_Arrow_up_SolidPink_RGB Access unrivaled historical detail, enabling you to examine R&D trends
Optimize business development and licensing strategies while identifying new opportunities
Assess the competitive landscape to identify development threats, gaps, or opportunities, and find fallen angels
Monitor major market trends such as drug launches, orphan drug status designations, or discontinuations



Pharmaprojects’ intuitive interface supports fast access to drug development insight for specific diseases, companies, and countries, and can support your strategic decision-making processes.

With our industry-leading platform you can:

  • Leverage dynamic dashboards to analyze trends by key data points
  • Identify fallen angels for in-licensing or partnership opportunities, and conduct your due diligence
  • Actively monitor competitive development and historical timelines, while identifying past successes and failures
  • Get direct access to our leading expert analysts through our ‘Ask the Analyst’ service




You can also access Pharmaprojects via our Drugs API so you can integrate, connect, and deliver multiple sources of information in real-time.

Pharmaprojects also offers seamless integration with Trialtrove and Sitetrove, our clinical trials and site/investigator intelligence solutions.



Thank you for requesting a demo

We have received your request and we will get back to you soon.

By continuing, you accept Pharma Intelligence UK may contact you with updates, relevant promotions and information about products provided by Pharma Intelligence UK. You understand that your information will be used in accordance with our Privacy Policy, and that you may withdraw your permission to receive any of our communications at any time.

You can unsubscribe at any time by following the links in any emails we send to you or by emailing See our Privacy Policy.